share_log

Illumina Shares Are Trading Lower After Barclays Maintained an Underweight Rating on the Stock but Raised Its Price Target From $130 to $175. The Company on Thursday Presented at Its Inaugural Illumina Genomics Forum.

Illumina Shares Are Trading Lower After Barclays Maintained an Underweight Rating on the Stock but Raised Its Price Target From $130 to $175. The Company on Thursday Presented at Its Inaugural Illumina Genomics Forum.

在巴克萊維持對Illumina的減持評級,但將其目標價從130美元上調至175美元后,Illumina的股價下跌。該公司週四在其首屆Illumina基因組學論壇上發表了講話。
Benzinga ·  2022/09/30 10:06

Illumina shares are trading lower after Barclays maintained an Underweight rating on the stock but raised its price target from $130 to $175. The company on Thursday presented at its inaugural Illumina Genomics Forum.

在巴克萊維持對Illumina的減持評級,但將其目標價從130美元上調至175美元后,Illumina的股價下跌。該公司週四在其首屆Illumina基因組學論壇上發表了講話。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論